Opinions
Hap (Robert) Sneddon FCSI
Windtree Therapeutics Inc
WINT-Q
COMMENT
Jun 06, 2013
$1.770
Stock price when the opinion was issued
Consumer Products
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
Chart indicates that it went back to visit the $1.50 level and was supported and went up from that point. It will probably have resistance at around the $2.40 level. The next point of resistance would be around $3.80.